All surgery carries some degree of risk. Though they are minimal, surgical risks include infection, bleeding, and excessive scarring. Risks that are specific to breast augmentation include:
This occurs when scar tissue develops around the implant, causing the breasts to feel hard and uncomfortable.
No implant is a life-long device. These devices are manmade and may leak. If one lives long enough with the implant, the implant may need to be replaced.
More often seen in subglandular (over-the-muscle) placement, rippling occurs when the outline of the implant is visible through the breast skin, causing a rippled appearance.
This term refers to what happens when the implant migrates lower than its original placement, gradually falling beneath the breast crease.
No woman has two identical breasts. Dr. Sorokin tells patients that they are “more like sisters than twins.” During different times of the month and throughout the years, breasts change size and shape. Dr. Sorokin guarantees all patients that some degree of asymmetry will exist and that a small amount of asymmetry is normal and expected. Larger degrees of asymmetry occasionally do occur during the healing process and could require revision.
This is a relatively new term that has been fueled more by social media than by scientific research. In fact there is no medical disease called Breast Implant Illness (BII) and yet as plastic surgeons we have seen women who come in with vague systemic complaints such as fatigue, rashes, hair loss, brain fog, muscle pains among other complaints. Indeed there are groups of women who believe their implants may be creating these symptoms and decide to get their implants removed. Dr. Sorokin believes that indeed some patients may not tolerate implants of any sort, be it a breast implant or a knee replacement and believes women should be aware of this phenomenon and if vague symptoms begin they should come in for an evaluation.
A rare breast implant associated lymphoma, known as Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) has been associated with the capsule (scar tissue) around the implant. In August of 2020, the FDA noted 733 worldwide confirmed cases of BIA-ALCL and 36 known deaths. Thus, this is a serious, but rare side effect. The implant most often associated with this disease has been removed from the market. It was a textured breast implant. Nearly all implants used in the United States at this time are smooth walled implants.
A Black Box Warning (a very strong warning that the FDA issues) explains to all patients and prospective patients:
- Breast Implants are not considered lifetime devices;
- The chance of developing complications increases over time;
- Some complications will require more surgery;
- Breast implants have been associated with the development of a cancer of the immune system called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)